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ARTICLE
Embryonic mesothelial-derived hepatic lineage of
quiescent and heterogenous scar-orchestrating
cells deﬁned but suppressed by WT1
Timothy James Kendall 1,2*, Catherine Mary Duff 1,2, Luke Boulter 1, David H. Wilson 1, Elisabeth Freyer1,
Stuart Aitken 1, Stuart John Forbes 3, John Peter Iredale2,4 & Nicholas Dixon Hastie1
Activated hepatic stellate cells (aHSCs) orchestrate scarring during liver injury, with putative
quiescent precursor mesodermal derivation. Here we use lineage-tracing from development,
through adult homoeostasis, to ﬁbrosis, to deﬁne morphologically and transcriptionally dis-
creet subpopulations of aHSCs by expression of WT1, a transcription factor controlling
morphological transitions in organogenesis and adult homoeostasis. Two distinct populations
of aHSCs express WT1 after injury, and both re-engage a transcriptional signature reﬂecting
embryonic mesothelial origin of their discreet quiescent adult precursor. WT1-deletion
enhances ﬁbrogenesis after injury, through upregulated Wnt-signalling and modulation of
genes central to matrix persistence in aHSCs, and augmentation of myoﬁbroblastic transition.
The mesothelial-derived lineage demonstrates punctuated phenotypic plasticity through
bidirectional mesothelial-mesenchymal transitions. Our ﬁndings demonstrate functional
heterogeneity of adult scar-orchestrating cells that can be whole-life traced back through
speciﬁc quiescent adult precursors to differential origin in development, and deﬁne WT1 as a
paradoxical regulator of aHSCs induced by injury but suppressing scarring.
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Activated hepatic stellate cells (aHSCs) are the predominantscar-orchestrating myoﬁbroblasts (MFBs) in ﬁbrotic liverinjury1 and have a critical role in primary liver carcino-
genesis2. These mesenchymal cells derive from activation of
perivascular quiescent HSCs (qHSCs)3. qHSCs are deﬁned by
retinoid storage but have diverse roles including vascular control4
and immunomodulation5,6. Activation of qHSCs involves reti-
noid remodelling, increased ﬁbrogenic gene expression, and
proliferation7.
Most ﬁbrosis in adult chronic liver disease is within the deep
parenchyma. A small proportion of subcapsular MFBs derive
from the adult WT1-positive mesothelium after injury but the
relevance of this is unclear8. A proportion of qHSCs in devel-
opment originate from the mesoderm9 via hepatic mesothe-
lium10. However, there remains uncertainty about the origin and
heterogeneity of the majority of deep parenchymal aHSCs after
adult injury and the functional signiﬁcance of the developmental
origin.
The hepatic mesothelium in both development and adulthood
is characterised by Wilms’ Tumour 1 (WT1) expression11.WT1 is
a transcription factor with a critical role in organogenesis in both
development12 and adult homoeostasis13. Critically, WT1 reg-
ulates signiﬁcant morphological plasticity, controlling mesench-
ymal states and, in many cases, deﬁning mesenchymal origin14,15.
Given the relationship between mesenchyme and WT1, we
examine WT1 expression by HSCs in ﬁbrotic liver disease. We
deﬁne discreet populations of aHSCs whose origin we trace
through adult precursors back to their ultimate embryological
source. We show that mesothelial origin in development deﬁnes a
speciﬁc population of qHSCs that is the precursor for distinct
populations of aHSCs after adult injury. Further, WT1 deletion
permits morphological transition to a MFB phenotype and
enhances ﬁbrotic response in an in vivo model of pericentral
ﬁbrosis, deﬁning WT1 as a paradoxical negative regulator of
ﬁbrogenic capacity during injury.
Results
Embryonic origin deﬁnes two discrete populations of qHSCs.
We sought to trace mesothelial-derived qHSCs from development
through adult homoeostasis into injury to determine the full
generational pathway of the most important scar-orchestrating
cells. Developmental labelling was induced in WT1CreERT2/+;
Ai14 mice at embryonic (E) day 10.5 (Fig. 1a), a time point
restricting labelling in the liver to the mesothelium10,16. Labelled
uninjured livers were stained for the lineage label (RFP) and an
HSC marker (platelet-derived growth factor β (PDGFRβ),
Fig. 1b). A subpopulation of 68.4 ± 3.46% of deep parenchymal
qHSCs was lineage labelled (mean ± s.e.m, n= 3 animals). No
RFP-positive cells were present in animals from control litters
that had not received maternal tamoxifen administration.
qHSCs were isolated by density centrifugation from the livers
of additional uninjured animals. Lineage label (RFP)-positive
and -negative qHSCs were analysed by ﬂow cytometry; 50.2 ±
3.8% were lineage-label positive (n= 11 animals). Representative
samples were used for RNAseq (n= 3 animals). Principle
component analysis demonstrated the separation of samples into
two groups, with lineage label-status representing the dominant
principal component (Fig. 1c). A total of 5716 genes were
differentially expressed (Supplementary Data 1), corresponding
to differential activation of 80 KEGG pathways (Supplementary
Data 2).
In lineage label-positive qHSCs, gene ontology (GO) terms
relating to morphogenesis and development were overrepresented
(Fig. 1d), particularly those associated with the vasculature
(‘vasculature development’, ‘endothelial cell migration’,
‘endothelium development’, and ‘circulatory system process’). In
contrast, the lineage label-negative population was overrepre-
sented by GO terms for responses to inﬂammation and immune
regulation.
qHSCs are the major source of extracellular matrix (ECM) in
the normal space of Disse, and expression of collagen and laminin
by both lineage label-positive and -negative qHSCs was
conﬁrmed. However, the ECM components expressed by lineage
label-positive and -negative cells were separate and complemen-
tary (Supplementary Table 1).
Injury activates WT1-positive cells of mesothelial lineage.
Adult male WT1CreERT2/+;Ai14 offspring, labelling induced at
E10.5, were chronically injured with carbon tetrachloride (CCl4)
injection (Fig. 2a). Livers were stained for the lineage label (RFP)
and α-smooth muscle actin (αSMA); a subpopulation represent-
ing 53.7 ± 10.4% of aHSCs carried the lineage label (n= 5
animals).
Given this indicated origin by activation of qHSCs derived
from the WT1-positive mesothelium, and the association of WT1
with morphological plasticity, livers were further stained for WT1
alongside the lineage label (RFP) and either another HSC marker
(glial ﬁbrillary acidic protein (GFAP)) or αSMA (Fig. 2b). In
uninjured control liver, there were no WT1-positive cells within
lobules (Supplementary Fig. 1); only the hepatic mesothelium and
rare cells located immediately beneath were WT1-positive. After
injury, the lineage-label persisted in colocalizing with the HSC
marker, but pericentral cells in the areas of scarring were WT1-
positive; 78.1 ± 5.3% of WT1-positive αSMA-positive cells carried
the lineage label compared with 20.5 ± 3.7% of WT1-negative
αSMA-positive cells (Fig. 2c; Welch two-sample t-test t(7.144)=
−7.9601, p= 8.437 × 10–5, 10 ﬁelds/animal, n= 5 animals).
Given the efﬁciency of both Cre-labelling and identiﬁcation of
labelled cells by immunoﬂuorescence, this indicates extensive
overlap between cells from a mesothelial-derived lineage and
WT1-positive cells after injury, and their membership of a
common lineage.
WT1 expression deﬁnes an aHSC subpopulation in ﬁbrosis. To
characterise the WT1-positive αSMA-positive cells in injured
liver further, ﬁbrotic tissue from a range of injury models was
examined. Large numbers of WT1-positive cells were present in
ﬁbrotic liver in all models of injury. WT1-positive cells were
present in models with pericentral injury (CCl4, Fig. 3a), mixed
portal and lobular injury (thioacetamide (TAA)), and biliary
injury (bile duct ligation (BDL) and 3,5-diethoxycarbonyl-1,4-
dihydrocollidine (DDC) diet, Supplementary Fig. 1).
WT1-positive cells were present within areas of ﬁbrosis
corresponding to the model-speciﬁc pattern of injury. For
example, after chronic injury with CCl4, WT1-positive cells were
located pericentrally, but no WT1-positive cells were present
within or adjacent to the uninjured portal tracts (Supplementary
Fig. 1).
WT1 immunopositivity was restricted to cells expressing
αSMA, GFAP, desmin, and PDGFRβ), identifying them as aHSCs
(Fig. 3a). There was no expression in cells expressing cytokeratins,
or with hepatocellular or biliary epithelial morphology (Supple-
mentary Fig. 1).
Human liver with a spectrum of ﬁbrotic diseases was examined
(Supplementary Fig. 1). Within the parenchyma, WT1 expression
was restricted to αSMA-positive cells within hepatic scars in
all cases.
aHSC populations vary in distribution and cell-cycle state. We
sought to determine the topographical distribution of
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subpopulations of aHSCs, deﬁned by WT1-status, within scars.
Sections of liver from wild-type animals chronically injured with
CCl4 were stained for WT1 and αSMA; 45.6 ± 2.3% of pericentral
αSMA-positive aHSCs were WT1 positive; 92.6 ± 1.6% of
WT1-positive cells were αSMA positive (1405 αSMA-positive
cells counted, 10 ﬁelds total, n= 3 animals). Only rare pericentral
WT1-positive cells were αSMA negative.
The nuclear positions of WT1-positive and WT1-negative
aHSCs were marked, and the central vein circumference deﬁned
(10 pericentral ﬁelds/animal, n= 6 animals). The distance of each
αSMA-positive cell nucleus to the closest point on the central vein
circumference was calculated (Fig. 3b and c). The WT1-positive
subpopulation of aHSCs was present throughout scars but a
signiﬁcantly larger proportion was closer to central veins
compared with more evenly distributed WT1-negative aHSCs
(Fig. 3d, bootstrapped Kolmogorov–Smirnov test for each animal,
p < 0.00001). The mean distance of WT1-positive aHSCs to
central vein was 27.0 ± 9.6 μm compared with 69.4 ± 7.8 μm for
WT1-negative cells (Fig. 3e, Welch two-sample t-test, t(9.6195)=
8.4046, p= 0.0000098).
Sections of liver from wild-type animals chronically injured
with CCl4 were also stained for Ki67 alongside WT1 and αSMA.
The proportion of aHSCs immunopositive for the proliferation
marker Ki67 was signiﬁcantly greater for WT1-negative com-
pared with WT1-positive aHSCs (Fig. 3f, Welch two-sample t-test
p < 0.001, 20.3 ± 0.9% versus 1.9 ± 0.7%, 10 pericentral ﬁelds/
animal, n= 3 animals).
Acute injury rapidly induces WT1-positive aHSC populations.
De novo activation of qHSCs was induced in wild-type animals
by a single CCl4 injection (0.25 μl g−1 body weight). Rare
WT1-positive aHSCs were present 3 days after injury (0.33 ± 0.33
WT1-positive cells/10 central vein proﬁles/animal) and in larger
numbers after 7 days (104.67 ± 4.67 WT1-positive cells/10 central
vein proﬁles/animal, n= 3 animals).
A larger dose of CCl4, causing greater hepatocellular necrosis
(Supplementary Fig. 2), induced more abundant WT1-positive
cells 3 days after injury. There was a strong positive correlation
between administered dose and WT1-positive cell number
(Spearman’s rank correlation rs= 0.8911, p= 0.01713, n= 3
animals, Supplementary Fig. 2).
WT1 deﬁnes morphologically distinct aHSC subpopulations.
To allow the morphological properties of aHSC subpopulations to
be examined, an in vitro model of activation by culture on plastic
was used. A green ﬂuorescent protein (GFP) reporter line
(WT1GFP/+) allowed isolation of WT1-positive cells17. qHSCs
from livers of uninjured WT1GFP/+ mice were isolated by ﬁeld-
standard density centrifugation based upon buoyancy that reﬂects
the lipid content speciﬁc to HSCs. Cells derived by this method
are accepted as meriting designation as HSCs. Isolated cells were
cultured on plastic for 7 days to full activation.
By ﬂow cytometry, <0.1% of viable cells present immediately
after isolation but before activation by culture on plastic were
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GFP positive (Supplementary Fig. 3). In fully activated cultures,
30.4 ± 4.6% of cells were WT1 positive (n= 12 animals). Within
the WT1-positive population, two distinct populations were
identiﬁed; 49.3 ± 6.7% of WT1-positive cells were GFP-high and
the remainder GFP-intermediate (Fig. 4a).
WT1 expression of sorted subpopulations by qPCR correlated
with GFP intensity (Spearman’s rank correlation rs= 0.962, p=
1.009 × 10–8, n= 5 animals, Supplementary Fig. 3). All sub-
populations expressed the well-characterised ﬁbrogenic activation
markers Acta1, Timp1, and Col1a1 (Fig. 4b). For each gene, there
was a statistically signiﬁcant difference between groups deter-
mined by one-way ANOVA (Acta1 F(2,12)= 11.72, p= 0.0015;
Timp1 F(2,12)= 11, p= 0.0019; Col1a1 F(2,12)= 4.496, p=
0.0349). The WT1-intermediate subpopulation showed higher
expression by post-hoc Tukey testing (p < 0.05).
The number of mesothelial cells from the surface monolayer is
low compared to the diffuse parenchymal population of qHSCs,
making it highly unlikely that mesothelial cells could signiﬁcantly
contaminate a selective HSC isolation. Further, there is no cogent
biological reason for mesothelial cell buoyancy to permit
contamination of the HSC isolate. However, we sought to exclude
the possibility of mesothelial contamination by labelling the
surface of the liver prior to liver digestion. qHSCs were isolated
from WT1GFP/+ animals after permanent ﬂuorescent labelling of
surface mesothelial cells in vivo (n= 3 animals, Supplementary
Fig. 3). Labelled contaminating cells were not found in cultures of
isolated HSCs during activation.
WT1-deﬁned subpopulations of aHSCs from further WT1GFP/+
animals, generated by culture on plastic, were obtained by FACS.
The WT1-high, WT1-intermediate, and WT1-negative
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subpopulations were plated separately back onto plastic and
allowed to adhere overnight.
WT1-high cells were round, whilst WT1-intermediate and
WT1-negative cells were classical MFB-shaped (Fig. 4c).
Morphometric analysis conﬁrmed that the population distribu-
tion of WT1-high aHSC ‘circularity’ was distinct from that of
both WT1-intermediate and WT1-negative aHSCs (Fig. 4d, p <
0.0001, boot-strapped Kolmogorov–Smirnov test for each
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replicate). Using multiple biological replicates, a statistically
signiﬁcant difference in mean cell circularity between groups was
conﬁrmed (Fig. 4e, one-way ANOVA F(2,21)= 4.997 p= 0.0168,
n= 8 animals).
To exclude the possibility that morphological differences
were a biophysical artefact of isolation by FACS, the
morphology of unsorted populations was examined using a
WT1CreERT2/+;Ai14 reporter line18,19 (Fig. 4f). RFP expression
in aHSCs was evident in half the cultured cells 24 h after Cre
induction at 6 days of culture on plastic. Two morphologies of
labelled cells were evident, rounded and classical MFB-shaped.
In contrast, most WT1(RFP)-negative cells were classical MFB-
shaped. Similarly treated cells were ﬁxed and stained for WT1
and RFP to conﬁrm efﬁcient label induction in WT1-positive
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cells and demonstrate the two distinct populations of
WT1-positive aHSCs (Fig. 4g).
WT1 status deﬁnes discrete aHSC transcriptional proﬁles. To
examine subpopulations of aHSCs in vivo, a cohort of adult male
WT1GFP/+ mice were chronically injured with CCl4 (Fig. 5a). The
two distinct populations of WT1-positive cells present after
activation in vitro were conﬁrmed in vivo by ﬂow cytometry of
freshly isolated HSCs from ﬁbrotic liver (Fig. 5b); the
WT1-positive subpopulations represented a much smaller pro-
portion of all isolated HSCs, as expected, given the presence in the
buoyant HSC fraction of the large majority of qHSCs from
uninjured parenchyma in addition to the WT1-negative aHSCs.
The transcriptomes of in vivo injury-generated WT1-positive
subpopulations was examined by microarray (n= 3 animals).
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Fig. 5 Subpopulations of aHSCs deﬁned by WT1 expression in chronic ﬁbrotic injury in vivo are transcriptionally distinct. a WT1GFP/+ animals were
iteratively injured with CCl4 to induce HSC activation and ﬁbrosis prior to isolation of subpopulations deﬁned by WT1(GFP) expression by ﬂow cytometry
(n= 3 animals). b Subpopulations of WT1(GFP)-high and WT1(GFP)-intermediate were present within the isolated HSC fraction from injured WT1GFP/+
animals (right panel) but not injured wild-type animals (left, representative plots with population percentages). c A multi-dimensional scaling plot of gene
expression after microarray analysis of WT1-positive in vivo activated and WT1-negative in vitro aHSCs demonstrated separation based on WT1(GFP)
expression. d Over and underexpressed probes between subpopulations of aHSCs determined by ﬁtting of a linear model. e Hierarchical clustering
independently separated subpopulations into groups deﬁned by WT1 expression
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A multi-dimensional scaling plot of raw expression data
demonstrated clustering of aHSC populations based on WT1
status (Fig. 5c). Hierarchical clustering independently separated
populations into groups deﬁned by WT1 expression, with the
WT1-high and WT1-intermediate subpopulations of aHSCs
more closely related to one another than either was to the
WT1-negative population (Fig. 5d, e, Supplementary Tables 2–7,
Supplementary Data 3–5).
The top overexpressed genes in both WT1-positive populations
included part of a mesothelial gene signature (Dmkn, Upk1b,
Upk3b, Msln, Gpm6a)20.
GO term differences between the morphologically distinct
WT1-high and WT1-intermediate aHSCs were accounted for
almost exclusively by overrepresentation in WT1-intermediate
cells of terms relating to immune response and regulation, cell
activation, response to wounding and inﬂammation, and
chemotaxis (Fig. 6a). This corresponded with activation of KEGG
pathways representing responses to inﬂammation, infection, and
injury (Supplementary Table 5) in WT1-intermediate cells.
Explicit mappings of differentially expressed genes to scarring-
related GO terms, showing upregulation in WT1-intermediate
cells in keeping with greater ﬁbrogenic capacity, are shown in
Fig. 6b, including matrix metalloproteinases, chemokine ligands,
chemokine receptors, and other genes implicated in ﬁbrogenesis;
Col1a1, Col1a2, Timp1, and Acta2 are not differentially expressed.
Of note, a number of the genes whose expression is upregulated
in the WT1-intermediate aHSCs have been shown to be central to
tissue scarring in mechanistic studies, including Pdgfrb21, Tgfb22,
Pf4 (Cxcl4)23, Ccl624, Ccl1125, Mmp1226, and Mmp327,28
(Supplementary Table 8). This suggests that the transcriptionally
distinct populations of aHSCs generated by in vivo injury may
inﬂuence ﬁbrogenesis by mechanisms more complex than simple
regulation of the transcription of genes encoding matrix
components.
There was common overrepresentation in both WT1-positive
populations of terms relating to cell activation, tissue morphol-
ogy, ECM, and cell adhesion. This corresponded to activation of
the KEGG pathway ‘ECM-receptor interaction’ and relative
inactivation of ‘NF-kappa B signalling’ in both WT1-positive
populations compared with WT1-negative cells (Supplementary
Tables 6 and 7). Terms relating to cell cycling and proliferation
were overrepresented in the WT1-negative population, as
expected given the signiﬁcantly higher Ki67 immunopositivity
of WT1-negative aHSCs.
Colocalization of cytoplasmic GFP and nuclear WT1 was
conﬁrmed in aHSCs and the mesothelium (Supplementary Fig. 4).
Colocalization in podocytes (in which WT1 is highly expressed)
was also conﬁrmed. As expected, GFP-positive cells in ﬁbrotic
livers also expressed αSMA.
To validate the microarray data, qPCR for 12 genes covering
the full range of differential expression (WT1-high versus WT1-
negative) was undertaken. There was a strong positive correlation
between differential gene expression determined by each method
(rs= 0.945, p= 2.443 × 10–6, Supplementary Fig. 4). The same
validation set was assessed in three paired populations of WT1-
high and WT1-negative aHSCs isolated by ﬂow cytometry after
in vitro activation of qHSCs from WT1GFP/+ animals. There was
a strong positive correlation of differential gene expression
between populations of aHSCs generated by in vivo injury and
in vitro activation (rs= 0.839, p= 0.001192), conﬁrming the
validity of in vitro generation of subpopulations of aHSCs as a
model for activation of qHSC in vivo (Supplementary Fig. 4).
Embryonic mesothelial lineage aHSCs are classically active.
Transcriptomic data from mesothelial-lineage label positive
qHSCs and WT1-positive aHSCs deriving from them after in vivo
injury were interrogated to deﬁne the transcriptional changes of
this discrete lineage. A total of 7406 genes were differentially
expressed between lineage-positive qHSCs and WT1-high aHSCs,
including 134 genes upregulated and 291 genes downregulated in
WT1-high aHSCs by at least 100-fold. A total of 5884 genes were
differentially expressed between lineage-positive qHSCs and
WT1-intermediate aHSCs, including 70 genes upregulated and
117 genes downregulated in WT1-high aHSCs by at least 100-
fold.
Both WT1-positive subpopulations of aHSCs show differential
upregulation of genes mapped to GO terms accepted as part of
the existing HSC activation paradigm, including ‘wound healing’,
‘extracellular matrix’, ‘actin cytoskeleton’, ‘inﬂammatory
response’, and ‘cytokine production’, supporting their designation
as a deﬁned lineage within this category of scar-orchestrating
cells (Supplementary Fig. 5). Individual genes mapping to
these key terms are illustrated in Fig. 6c and Supplementary
Fig. 5 (complete list in Supplementary Data 6 and 7). There is
signiﬁcant downregulation of Ctrb1 (chymotrypsinogen B1) in
both WT1-high and WT1-intermediate aHSCs compared
with qHSCs.
Upregulation of these classical activation processes is accom-
panied in both WT1-positive subpopulations of aHSCs by
downregulation of processes associated with quiescent cellular
function.
Mesothelial lineage cells re-engage a mesothelial signature. The
transcriptomic data from subpopulations of qHSCs and aHSCs
were speciﬁcally interrogated to deﬁne the expression of a
comprehensive, manually curated mesothelial-associated
proﬁle20,29–33 throughout their lineage (Fig. 7a). Strong
expression of this gene expression signature was only present in
WT1-intermediate and WT1-high aHSCs after injury and acti-
vation and expression was greater in the WT1-high population;
these populations derive from precursor quiescent cells with
ultimate origin from the embryonic mesothelium. WT1-negative
aHSCs, selectively deriving from non-mesothelial derived
quiescent precursors, do not engage this gene signature. There
was no expression of mesothelial-associated genes in any qHSC
population isolated from uninjured animals; this further
indicates the absence of contamination of HSC isolates by non-
buoyant mesothelial cells derived by density centrifugation.
Mesothelium is the source of subcapsular WT1-positive aHSC.
Previous reports have identiﬁed the adult hepatic mesothelium as
a source of subcapsular aHSCs after injury8. The WT1CreERT2/+;
Ai14 lineage tracing line was used to determine the WT1 status of
this limited subcapsular population.
Lineage labelling was induced in adult male WT1CreERT2/+;
Ai14 mice prior to chronic CCl4 injury (Fig. 7b). Activated HSCs
were signiﬁcantly more likely to be WT1-positive if they carried
the lineage label reﬂective of mesothelial origin (Fig. 7c). 70.5 ±
4.7% of lineage labelled aHSCs were WT1-positive compared
with 42.2 ± 5.9% of unlabelled aHSCs (Welch two-sample t-test, t
(6.0798)=−5.1437, p= 0.002), conﬁrming a speciﬁc relationship
between mesothelial origin and WT1 status in adult injury, in
addition to the equivalent relationship with mesothelial origin in
development. WT1-positive aHSCs accounted for 45.8 ± 7.4% of
the total aHSC population, a similar proportion to that observed
in pericentral scars (10 pericentral ﬁelds/animal, n= 5 animals).
Within the total subcapsular population of aHSCs, lineage-
labelled cells accounted for only 5.0 ± 3.6% of the total
population.
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Fig. 6 The transcriptional proﬁles of aHSC populations deﬁned by WT1 expression are classically activated but distinct, with enhanced scar-related
processes in WT1-intermediate cells. a GO term analysis of differentially expressed genes between subpopulations of aHSCs deﬁned by WT1 expression
demonstrate signiﬁcant differences in proﬁles between all subpopulations, with WT1-high and WT1-intermediate populations showing fewer differences.
b Speciﬁc mapping of differentially expressed genes to GO terms for indicative scarring responses demonstrate the enhancement in WT1-intermediate
aHSCs compared with WT1-high aHSCs. c The transcriptome, determined by RNAseq, of aHSCs isolated from PDGFRβCre;WT1GFP/+ animals (n= 6) with
liver ﬁbrosis induced by iterative injury with CCl4 was compared with that of quiescent lineage-label positive HSCs from WT1CreERT2/+;Ai14 animals (n=
3) induced at E10.5. Gene ontology terms mapped to differentially expressed genes for WT1-high cells demonstrate engagement of cellular processes
associated with the HSC activation paradigm
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Loss of WT1 expression from aHSCs increases ﬁbrosis. The
functional role of WT1 was determined by selective deletion from
HSCs and MFBs using a constitutive PDGFRβCre line34 (Fig. 8a).
Cohorts of wild-type (n= 6 animals) and PDGFRβCre;WT1−/ﬂ
(WT1-deleted, n= 11 animals) male mice were chronically
injured by CCl4 injection, and sections of liver stained for WT1.
There was a 64.3% reduction in the number of WT1-positive
pericentral cells in WT1-deleted animals compared with wild-type
animals (Fig. 9b, 295.8 ± 59.4 vs 829.8 ± 116.3 WT1-positive cells/
10 pericentral ﬁelds, n= 6 animals; Welch two-sample t-test, t
(7.4397)=−4.0896, p= 0.00407). The reduction in the number of
WT1-positive aHSCs was accompanied by a 67.56% increase in
ﬁbrosis after injury (Fig. 8c, 8.1 ± 0.6% vs 4.8 ± 0.5% picro-sirius red
(PSR) positivity; Welch two-sample t-test, t(13.765)=−4.194, p=
0.0009388). There was no difference in the number of scar-
orchestrating αSMA-positive cells present (Fig. 8d, 1007.8 ± 273.8
vs 927.0 ± 186.5 αSMA-positive cells/10 pericentral ﬁelds; Welch
two-sample t-test, t(8.819)=−0.244), p= 0.8128).
To determine if WT1-deleted cells persisted in the liver to
coordinate enhanced ﬁbrogenesis, a PDGFRβCre;WT1GFP/ﬂ line,
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in which GFP reporting from the WT1 locus remained in WT1-
deleted animals, was generated. A cohort of male PDGFRβCre;
WT1GFP/ﬂ animals was injured by CCl4 injection for 8 weeks
(n= 4 animals). 76.2 ± 3.6% of GFP-positive pericentral cells
were WT1-negative (Fig. 8e); no cells were WT1 single positive
(GFP-negative). This indicates the persistence of theWT1-deleted
populations of MFBs during enhanced ﬁbrogenesis.
WT1 loss enhances ﬁbrotic HSC transcription and transition.
To allow examination of residual MFBs in WT1-deleted animals
from which WT1 expression had been lost, an additional Cre
reporter line was generated (PDGFRβCre;WT1GFP/ﬂ;Ai14). Male
PDGFRβCre;WT1GFP/ﬂ;Ai14 (labelled WT1-deleted) and control
PDGFRβCre;WT1GFP/+;Ai14 animals were chronically injured by
CCl4 injection (n= 6 animals). Quiescent and activated HSCs
were isolated the day after the ﬁnal injection by density cen-
trifugation. Cre reporter (RFP) positive GFP-high and GFP-
intermediate aHSCs were obtained by FACS from both labelled
WT1-deleted and control animals and used for RNAseq analysis.
In GFP-high aHSCs, 40 genes were upregulated after WT1
deletion compared with only ten that were downregulated
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(Supplementary Data 8). Upregulated genes mapped to the GO
terms ‘proteinaceous extracellular matrix’ and ‘extracellular
region’; the limited number of downregulated genes did not
map signiﬁcantly to any GO term.
In GFP-intermediate aHSCs, 155 genes were upregulated and
170 downregulated after WT1 deletion (Supplementary Data 9).
For those genes that were upregulated in GFP-intermediate cells,
GO terms ‘extracellular matrix organisation’ and ‘extracellular
region’, terms for positive regulation of non-canonical Wnt
signalling, responses to growth factors and cell surface receptors,
and morphological cellular and developmental transitions were
represented (Fig. 9a). In contrast, downregulated genes mapped
to GO terms relating to immune and inﬂammatory responses,
and DNA replication.
This suite of responses toWT1 loss suggests two broad roles for
WT1 in aHSCs in ﬁbrotic disease. Upregulation of ‘extracellular
matrix organisation’, ‘responses to extracellular stimuli’, and ‘non-
canonical Wnt signalling’ after WT1 loss suggests that WT1 has a
tonic inhibitory role that limits ﬁbrogenesis during injury. The
most downregulated gene in GFP-intermediate cells after
WT1-deletion was Ctrb1 (log fold-change −9.35, adjusted p-value
0.016). Downregulation of immune and inﬂammatory functions
in the GFP-intermediate subpopulation, the same functions
overrepresented in WT1-intermediate compared with WT1-high
aHSCs, indicates a critical role for WT1 orchestrating these
additional functions of aHSCs not directly related to scarring.
The upregulation genes mapping to morphological cellular and
developmental transitions in the WT1-deleted GFP-intermediate
subpopulation merited morphological evaluation of aHSCs.
Morphology of aHSCs could not be reliably quantitated in situ
after in vivo injury, soWT1 deletion during in vitro activation was
examined. qHSCs were isolated from uninjured WT1CreERT2/ﬂ;
Ai14 animals (where Cre mediated excision of the single ﬂoxed
allele completely prevents WT1 expression), and the morphology
of RFP (Cre-reporter) aHSCs examined after 7 days under the
condition of WT1 deletion. Control cultures derived from
WT1CreERT2/+;Ai14 animals, where tamoxifen addition induces
RFP expression alone, were used.
The mean circularity of all RFP-positive aHSCs reduced
by 17.5% with WT1 deletion (from 0.55 ± 0.01 to 0.45 ± 0.01).
The population density distributions of circularity of activated
RFP-positive cells with WT1 deletion was signiﬁcantly different
from that of control RFP(WT1)-positive cells (Fig. 9b, boot-
strapped two-sample Kolmogorov–Smirnov test, p= 0.002,
345 cells from representative experiment of three independent
cell preparations). The demonstrable transition from a dominant
round morphology in WT1-positive aHSCs to MFB-shaped cells
afterWT1-deletion is consistent withWT1maintaining the round
morphology associated with reduced ﬁbrogenic capacity in
WT1-high cells during injury.
Discussion
Activation of qHSCs is the dominant process generating scar-
orchestrating cells during ﬁbrotic liver injury1. We have
demonstrated profound transcriptional, morphological, and
ﬁbro-spatial heterogeneity of aHSCs after injury, deﬁned by WT1
expression. Recognising and understanding the functional sig-
niﬁcance of aHSC heterogeneity will inform more nuanced
understanding of ﬁbrogenesis, akin to heterogeneity in perivas-
cular cells in injury deﬁned in other systems35. For example,
injury with CCl4 is pericentral, and scarring develops radially
with continued damage; WT1-positive populations of aHSCs are
rapidly evident after injury and are most closely apposed to
central veins, so may represent a speciﬁc initiator population of
ﬁbrogenic cells.
Separate populations of aHSCs, deﬁned by WT1 expression,
have distinct transcriptional proﬁles and ﬁbrogenic capacities.
The WT1-high population is rounded whilst the WT1-inter-
mediate, most ﬁbrogenic, population is classical MFB-shaped.
Deletion of WT1 promoted the formation of these classical MFBs,
with enhanced expression of genes associated with developmental
and cellular transitions, suggesting that WT1 may be controlling
population plasticity and that high WT1 levels maintain the less
ﬁbrogenic phenotype.
We have also demonstrated that precursor qHSCs in the
uninjured adult liver are members of distinct lineages, dependent
upon mesothelial or non-mesothelial developmental origin, and
offering a developmental basis for previously recognised
heterogeneity36,37. Further, lineage membership deﬁnes discrete
transcriptomic proﬁles suggesting signiﬁcant functional differ-
ences. The recognition of population diversity based upon
developmental lineage is important to drive investigation of HSC
biology; potential functions attributed to qHSCs can be segre-
gated based upon origin, with mesothelial-derived qHSCs having
upregulated GO terms indicating functions relating to vasculature
regulation and qHSCs of non-mesothelial origin having GO term
upregulation for immune and injury response-related functions.
Furthermore, the heterogenous qHSC populations are com-
plementary in their collagen contribution to the space of Disse.
Mesothelial derivation of a subpopulation of qHSCs is analogous
to the mesothelial origin of a proportion of visceral white adipose
tissue18, indicating that mesothelial origin is a common source of
functionally signiﬁcant heterogeneity in mesothelial-covered
organs15,38.
Critically, these previously unrecognised subpopulations of
HSCs in the homoeostatic and ﬁbrotic liver can be deﬁned as part
of a complete discreet lineage (Fig. 10); WT1-positive scar-
orchestrating cells derive from a qHSC population that is
enhanced for pericyte functions and whose ultimate origin is the
hepatic mesothelium during development. Identiﬁcation of
mesothelial-derived qHSCs throughout lobules in homoeostasis
Fig. 8 Loss of WT1 expression by PDGFRβ-expressing HSCs and myoﬁbroblasts causes an enhanced ﬁbrotic response to chronic injury without a change in
myoﬁbroblast number. a Chronic ﬁbrosis was induced by iterative injury with CCl4 in animals in which WT1 had been constitutively deleted, or control
animals. b The number of WT1-positive aHSCs after chronic injury in PDGFRβCre;WT1−/ﬂ animals is signiﬁcantly reduced compared with wild-type
animals (295.8 ± 59.4 vs 829.8 ± 116.3 WT1-positive cells/10 pericentral ﬁelds, n= 6; Welch two-sample t-test, t(7.4397)=−4.0896, *p= 0.00407).
Example pericentral ﬁelds from the livers of injured wild-type and WT1-deleted animals stained for WT1 and αSMA are shown. Scale bars 100 μm. c There
is an enhanced ﬁbrotic response to chronic injury in WT1-deleted PDGFRβCre;WT1−/ﬂ animals (whole-slide PSR quantiﬁcation of ﬁbrotic matrix, 8.1 ±
0.6% vs 4.8 ± 0.5%, n= 6 (wild-type), n= 11 (PDGFRβCre;WT1−/ﬂ); Welch two-sample t-test, t(13.765)=−4.194, *p= 0.0009388). Example PSR-
stained sections of whole lobes of the livers of injured wild-type and WT1-deleted animals are shown. Scale bars 1 mm. d The enhanced ﬁbrotic response
to chronic injury in PDGFRβCre;WT1−/ﬂ animals is not associated with increased numbers of aHSCs compared with wild-type animals (1007.8 ± 273.8 vs
927.0 ± 186.5 αSMA-positive cells/10 pericentral ﬁelds; Welch two-sample t-test, t(8.819)=−0.244), p= 0.8128). Data are represented as individual
points with median (centre line), ﬁrst and third quartiles (lower and upper box limits), 1.5× interquartile range (whiskers). e The use of PDGFRβCre;
WT1GFP/ﬂ animals allows continued GFP reporting to demonstrate the persistence of WT1-deleted aHSCs after pericentral chronic injury. Scale
bars 100 μm
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and WT1-positive scar-orchestrating cells in all models and
human diseases indicates that mesothelial origin of distinct
quiescent precursors capable of generating deﬁned subpopula-
tions of scar-orchestrating cells is an injury-agnostic, fundamental
feature of hepatic ﬁbrogenesis. These relationships between
embryonic mesothelial origin and heterogeneous populations of
quiescent progenitors and scar-orchestrating cells may be shared
in other mesothelial covered organs, particularly the pancreas.
Obviously, we have deﬁned the complete cellular lineage of half of
the scar-orchestrating cells after liver injury; the possible
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heterogeneity and alternative origin(s) of the WT1-negative cells
have not been sought.
Categorical demonstration that pericentral aHSCs after injury,
present deep within the parenchyma and without mesothelial
contamination, express a signature of genes previously identiﬁed
in the mesothelium identiﬁes a unique inter-generational sig-
niﬁer. Only the populations whose ancestry traces to the
embryonic mesothelium express this transcriptional signature
and its re-engagement reﬂects their lineage. The biphasic mor-
phology evident in these activated adult cells is akin to that seen
in mesothelial malignancy (mesothelioma) or some forms of
Wilms’ tumour. This suggests that WT1-related morphological
plasticity is not limited to malignant disease but occurs in
scarring after injury in situations where a mesothelial origin for
Fig. 9 Loss of WT1 expression by aHSCs upregulates extracellular matrix and other proﬁbrotic transcriptional pathways and permits transition to a
myoﬁbroblast morphology. a Genes mapping to GO terms for ‘extracellular matrix’, morphological and developmental transitions, non-canonical Wnt
signalling and responses to growth factors are upregulated following WT1 loss in PDGFRβCre;WT1−/ﬂ animals after iterative injury with CCl4 in vivo. Genes
mapping to immune and inﬂammatory responses and DNA replication are downregulated. b The population density distributions of circularity of activated
RFP-positive cells under the condition of WT1 deletion was signiﬁcantly different from that of control RFP(WT1)-positive cells (Bootstrapped two-sample
Kolmogorov–Smirnov test, p= 0.002) during activation of qHSCs isolated from WT1CreERT2/ﬂ;Ai14 animals in vitro, demonstrating a shift from round to
myoﬁbroblast-shaped aHSCs. Representative of three biological replicates. Scale bars 100 μm
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Fig. 10 WT1 is a paradoxical negative regulator of ﬁbrogenesis in distinct subpopulations of aHSCs deﬁned by WT1 expression. WT1-positive
subpopulations in liver injury are generated by activation of speciﬁc progenitors that derive from the embryonic hepatic mesothelium in early development.
Developmental origin determines the functional categorisation of qHSCs; those derived from the mesothelium demonstrate engagement of vascular
regulatory pathways, whilst those from non-mesothelial sources have immunomodulatory transcriptional proﬁles
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12701-9
14 NATURE COMMUNICATIONS |         (2019) 10:4688 | https://doi.org/10.1038/s41467-019-12701-9 | www.nature.com/naturecommunications
scar-orchestrating can be identiﬁed. Whilst a shared micro-
architectural location and buoyancy reﬂective of lipid storage
merits designation of both populations as quiescent hepatic
stellate under current dogma, the differences in developmental
origin, quiescent transcriptomic proﬁle, and phenotype in
response to injury of the lineages raise the possibility that these
could legitimately be considered to be completely different
cell types.
Deletion of WT1 from PDGFRβ-positive HSCs did not lead to
cell loss; instead, persisting subpopulations orchestrated enhanced
ﬁbrogenesis. The associated change in transcriptional proﬁles
after deletion were those of enhanced growth factor responsive-
ness and non-canonical Wnt signalling rather than purely upre-
gulation of ECM gene expression. The most downregulated gene
after WT1 loss was Ctrb1; in addition to documented matrix
degradative capacity39, known and predicted protein–protein
interactions of chymotrypsinogen B1 documented by the
STRING database40 are dominated by interactions with matrix
metalloproteinases, serine proteases, and peptidase inhibitors
(Supplementary Fig. 6). Given the signiﬁcantly enhanced scarring
after WT1 deletion, this suggests that Wnt-signalling has a critical
role driving HSC scarring capacity, requiring suppression by
WT1 and that chymotrypsinogen B1 could be explored as a
central node in the network of post-translational modiﬁers of
matrix accumulation and remodelling.
Mesothelium, as the name indicates, is characterised by both
mesenchymal and epithelial properties, strongly expresses WT1,
and is increasingly recognised as a highly specialised tissue. WT1
has a well-deﬁned role in controlling morphological transitions.
In the developing kidney, WT1 is required for nephron formation
by regulating mesenchymal–epithelial transition14. Conversely,
WT1 is required for the formation of mesenchymal lineages in
the heart by epithelial–mesenchymal transition of the epi-
cardium12. The epicardium is the cardiac mesothelium, so this
may be better deﬁned as mesothelial–mesenchymal transition.
In the classical model of hepatic ﬁbrogenesis, morphological
plasticity of HSCs is accepted during activation. More profound
HSC plasticity in the liver is more contentious41. Although there
is evidence to indicate epithelial regenerative capacity after injury
by formal mesenchymal–epithelial HSC transition42–45, with
Hedgehog signalling central to this, and the formation of HSCs by
epithelial–mesenchymal transition of hepatic epithelia, other
studies do not support such transitions46,47.
Given the precedent of WT1 regulation of epithelial-
mesenchymal transition and mesenchymal-epithelial transition,
and the role of the mesothelium in this, it is important to
explicitly evaluate our ﬁndings in the context of such transitions.
We have demonstrated signiﬁcant punctuated and bidirectional
morphological plasticity throughout the complete temporal
extent of the mesothelial-derived HSC lineage, supporting the
capacity for extreme ﬂexibility by this HSC lineage suggested by
earlier work. At the point of developmental origin of the lineage
there is mesothelial–mesenchymal transition10. Subsequent
responses to adult injury could be interpreted as a partial reversal
of this by mesenchymal–mesothelial transition, indicated by both
the re-engagement of a WT1-high mesothelioid gene signature
and the acquisition of a characteristic ‘rounded’ morphology; a
classical (‘activated’) scar-orchestrating transcriptional proﬁle is
also acquired. At the same time a distinct, more ﬁbrogenic,
population of aHSCs within the same lineage re-engages the
mesothelial gene proﬁle to a lower level and demonstrates a
classical MFB shape. The WT1-high population after adult injury
expresses the high levels of the Smo, the regulator of HSC tran-
sitions deﬁned by the study of Michelotti et al.42, as part of the re-
engagement of a mesothelial signature. Finally, whilst loss of
expression of WT1 by HSCs did not change the expression of the
mesothelial gene signature, including Smo, it permitted greater
scar formation through enhanced aHSC ﬁbrogenic transcriptional
proﬁle expression but no change in cell number. This was asso-
ciated with a morphological shift to favour the myoﬁbroblastic
morphology, a ﬁnding that could be considered a failure of scar-
mitigating mesenchymal–mesothelial transition during injury or
as a ﬁnal, aberrant mesothelial-MFB transition.
Intrinsic proﬁbrotic factors induced by activation in HSCs by
injury are well described, and antiﬁbrotic intrinsic factors present
within qHSCs have been observed to diminish during injury48.
However, WT1 represents a new paradoxical category of intrinsic
regulatory factors, one that is antiﬁbrotic but induced only in
injury; this may permit additional means of ﬁne-tuning of the
ﬁbrotic response.
Methods
Murine line details and generation. The animals used for injury modelling in this
study were all on a C57Bl/6 background aged within 8–12 weeks old and >20 g
body weight at the start of the experiments. Male mice were used for in vivo
studies; male and female mice were used for in vitro studies. Animals were housed
in a speciﬁc pathogen-free environment and kept under standard conditions with a
12 h day/night cycle and access to food and water ad libitum. All animal experi-
ments were carried out under procedural guidelines, severity protocols and with
ethical approval from the University of Edinburgh Animal Welfare and Ethical
Review Body (AWERB) and the Home Ofﬁce (UK).
Separate power calculations were not routinely performed; however, animal
numbers were chosen to reﬂect the expected magnitude of response taking into
account the variability observed in previous experiments.
For mechanistic experiments where a change in ﬁbrotic response was expected,
a power calculation using the anticipated efﬁcacy of modiﬁcation was used.
An assumption of a 30% change in collagen content between transgenic and
normal animals was used, with an 80% chance of detecting this expected difference
accepted; using our previous data regarding population distribution and effect
size, and for a two-sided signiﬁcance level of 5% and power of 80%, at least six
animals per group were required to compare normal versus knockout/transgenic
mice where ﬁbrosis is quantiﬁed by PSR staining.
WT1GFP/+ knockin reporter mice were originally provided by Sugiyama17
(Osaka University School of Medicine, Japan).
WT1CreERT2/+;Ai14 mice for lineage tracing were created by crossing knockin
mice expressing tamoxifen-inducible Cre recombinase at the WT1 promoter
locus18 (WT1CreERT2/+) with the Ai14 Cre reporter19. In this reporter line, a
construct containing the CAG promoter followed by ﬂox-STOP-ﬂox controlled
tdTomato has been inserted into the wild-type Rosa26 locus. In the WT1CreERT2/+;
Ai14 line, Cre-mediated excision of the stop codon allows cytoplasmic tdTomato
expression in WT1-positive cells and their progeny, after induction with
4-hydroxytamoxifen.
The WT1-conditional background (WT1ﬂ/ﬂ)12 was used to create lines allowing
WT1 deletion. For selective deletion of WT1 from qHSCs, the constitutive
PDGFRβCre line was obtained from Henderson et al.34. PDGFRβCre males were
crossed with WT1ﬂ/ﬂ females to create PDGFRβCre;WT1+/ﬂ animals; there is
germline PDGFRβ expression such that only the WT1 null allele is transmitted. To
generate PDGFRβCre;WT1−/ﬂ animals, PDGFRβCre;WT1+/ﬂ males were crossed
with WT1fl/ﬂ females.
To allow identiﬁcation and isolation of persisting aHSCs showing loss of expected
WT1 expression, PDGFRβCre;WT1GFP/+ males were crossed with WT1ﬂ/ﬂ females
to generate the PDGFRβCre;WT1GFP/ﬂ line; the control PDGFRβCre;WT1GFP/+;
Ai14 line was generated by crossing PDGFRβCre;WT1GFP/+males were crossed with
WT1+/+;Ai14 females.
Finally, for inducible deletion of WT1 during in vitro activation, male
WT1CreERT2/+;Ai14 animals were crossed with WT1ﬂ/ﬂ females to generate the
WT1CreERT2/ﬂ;Ai14 line.
Chronic ﬁbrotic in vivo injury models. Liver ﬁbrosis was induced in cohorts of
male mice by 4 or 8 weeks CCl4 injection twice weekly, 0.25 µl g−1 body weight in a
1:3 ratio with sterile olive oil49, or vehicle alone. CCl4 undergoes conversion to the
CCl3 radical in pericentral hepatocytes, and CCl3 initiates lipid peroxidation
leading to hepatocellular death. The resultant inﬂammation leads to activation of
HSCs and the development of pericentral ﬁbrosis with spur formation and early
central–central bridging ﬁbrosis over this period. Mice of the appropriate genotype
were randomly allocated to olive oil or carbon tetrachloride injection as they
became suitable for model participation. Blinding to control or injury groups was
not possible as the injury is macroscopically and microscopically apparent.
WT1GFP/+ mice were injured for 8 weeks and culled 1 day after the ﬁnal
injection for isolation of HSC populations by ﬂow cytometry (n= 3) or 3 days after
for histological examination (n= 6).
Sections of formalin-ﬁxed parafﬁn-embedded ﬁbrotic liver from wild-type mice
generated by alternative models of liver ﬁbrosis with complementary histological
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patterns of injury were obtained (n= 3 for each model). BDL and DDC50 dietary
injury cause bile duct obstruction leading to inﬂammatory portal and periportal
injury and ﬁbrosis, modelling destructive peripheral cholangiopathies. TAA
administration51 induces both periportal and pericentral ﬁbrosis to model diseases
with portal, interface and lobular hepatitis (e.g. Autoimmune Hepatitis (AIH)).
Acute CCl4 injury in vivo. Acute injury causing de novo activation of qHSCs was
induced in wild-type animals by a single intraperitoneal injection of CCl4 (0.25 μl g−1
or 1 μl g−1 body weight) or olive oil vehicle, as described34. Cohorts of animals were
culled the day following injury to allow determination of the induced hepatocellular
necrosis (n= 4, 0.25 µl g−1; n= 3, 1 µl g−1). To quantify WT1-positive cell number
following injury, cohorts injured with an injection of 0.25 µl g−1 CCl4 were culled 3
and 7 days after injury (n= 3), and cohort injured with 1 µl g−1 CCl4 or vehicle
control culled 3 days after injury (n= 3). Animals were not randomised to injury or
control groups. Blinding to control or injury groups was not possible as the injury is
macroscopically and microscopically apparent.
Lineage labelling in vivo. Nuclear Cre translocation and labelling of WT1-positive
cells were induced in adult WT1CreERT2/+;A14 mice by 5 consecutive days of
tamoxifen IP injections (100 mg kg−1). To trace the contribution of the mesothe-
lium to the adult HSC population in the absence of injury, cohorts of female
animals were culled without injury up to 45 days after labelling (n= 3/time point).
To determine the contribution of the adult hepatic mesothelium to the WT1-
deﬁned subpopulations of aHSCs, a cohort of male animals was used for 4 weeks of
chronic ﬁbrotic injury with CCl4, beginning on the ﬁnal day of tamoxifen
administration (n= 5). No labelling is evident without tamoxifen injection.
Blinding to tamoxifen administration status is not possible as Ai14 label is mac-
roscopically apparent.
To generate developmentally induced WT1 lineage-labelled HSCs, male
WT1CreERT2/+;Ai14 mice were crossed with wild-type female mice. Pregnant
females received a single gavaged dose of tamoxifen (200 mg kg−1) at E10.5. Pups
were delivered by Caesarean section at E18.5 and fostered onto a wild-type post-
partum female. Male lineage-labelled animals were used for chronic ﬁbrotic injury
with CCl4 (n= 5), and female lineage-labelled animals used for examination of
lineage-labelled populations with immunoﬂuorescence (n= 3) or isolation of
labelled and unlabelled qHSCs for RNAseq (n= 3). No labelling is evident without
maternal tamoxifen administration. Blinding to tamoxifen administration status is
not possible as Ai14 label is macroscopically apparent.
In vivo surface mesothelial labelling. Surface mesothelium was labelled by the
intraperitoneal injection of a single dose of a non-toxic ﬂuorescent surface dye
(CellTracker Red CMTPX, Thermo Fisher Scientiﬁc), as per manufacturer’s
instruction (1:1000 dilution of 10 mM stock solution in sterile PBS, 5 μl g−1 body
weight) for 60 min before sacriﬁce.
Human explant studies. Human tissue was obtained by approved application to
the Lothian NRS Human Annotated Bioresource that is authorised to provide
unconsented anonymised tissue under ethical approval number 15/ES/0094 from
the East of Scotland Research Ethics Service REC 1. Sections of formalin-ﬁxed
parafﬁn-embedded explant ﬁbrotic human liver from the deep right lobe, removed
at the time of orthotopic liver transplantation, were received from eight cases (two
cases of alcoholic liver disease, two cases of primary biliary cirrhosis, two cases of
cryptogenic cirrhosis, and one each of chronic viral hepatitis (HCV), and primary
sclerosing cholangitis). Explant livers were received fresh on ice and ﬁxed imme-
diately by the installation of 4% v/v neutral buffered formalin (Genta medical, UK)
via the hepatic veins. All tissue was from cases from 2006 onwards and received
anonymised to all details other than aetiology.
Histology and quantitative pathology. Samples of each lobe of livers were
immediately formalin-ﬁxed before parafﬁn-embedding in a single block to allow
histological examination. Haematoxylin-and-eosin-stained sections were prepared
from each animal. PSR-stained sections were prepared52 and whole-slide images
acquired with Dotslide VS-ASW software using a motorised stage and an Olympus
BX51 microscope, using an Olympus PlanApo 2X lens and Olympus XC10 camera.
The PSR-positive proportion of all tissue from each whole-slide image was
determined after applying the same colour threshold to all images as a script within
the FIJI53 implementation of ImageJ254.
For immunoﬂuorescence, antigen retrieval was achieved by microwaving in
Tris-EDTA pH 9.0. Endogenous peroxidase activity was blocked by 3% (v/v in
phosphate-buffered saline) H2O2 pretreatment. Primary antibodies at appropriate
dilutions were applied and slides incubated at room temperature for 1 h or 4 °C
overnight. Details of primary antibodies and dilutions are given in Supplementary
Table 9. Negative controls were performed using identical concentrations of species
and isotype-matched non-immune immunoglobulin in place of primary antibody
(where details were available) or omission of primary antibody.
To determine ﬁbro-spatial data from individual cells after CCl4 injury,
10 pericentral ﬁelds (×20 objective lens) were acquired using a Zeiss Axioplan II
microscope and Photometrics CoolSNAP HQ2 camera (n= 6). Nuclear location of
cells and central vein outlines were marked for each in FIJI, and points of interest
imported into R. The nearest point to the central vein of each cell was determined
using spatstat55. Population distributions based on distance to central vein were
assessed by a bootstrapped version of the Kolmogorov–Smirnov test using the
Matching package56.
For confocal colocalization of HSC markers with WT1 or GFP after CCl4 injury,
images were acquired from a total of 10 pericentral ﬁelds from three biological
replicates using a Nikon A1R confocal microscope.
To histologically quantify necrosis after acute injury, slides were scanned to
create a single image with Dotslide VS-ASW software using a motorised stage and
an Olympus BX51 microscope, acquiring images using an Olympus PlanApo 2X
lens and Olympus XC10 camera. Images were analysed using the Trainable
Segmentation plugin57 implementing WEKA58 in FIJI. A separate classiﬁer
identifying necrotic and viable tissue was determined and applied to all tissue in
each image.
Flow cytometry analysis and sorting. Analysis and sorting of HSCs derived from
WT1GFP/+, WT1CreERT2/+;Ai14, PDGFRβCre;WT1GFP/ﬂ, and PDGFRβCre;
WT1GFP/+;Ai14 animals was undertaken using a FACSAria (BD). Freshly isolated
cells from injured or uninjured liver were used after red cell lysis. Data were
analysed using FlowJo. For in vitro activation studies, data were collected from
12 independent cell preparations; sorting into separate subpopulations deﬁned by
WT1 expression was undertaken directly for RNA preparation (n= 5) or for
further culture and morphological studies (n= 8); cells from one preparation were
sorted for both purposes on one occasion. Sorting based on single channel WT1GFP
expression was as documented in the relevant plots; strategies for Ai14 Cre-
reporter lines are shown in Supplementary Fig. 7.
Hepatic stellate cell isolation and in vitro studies. Quiescent and activated
HSCs were isolated, after digestion, by density centrifugation as described59. qHSCs
isolated from uninjured livers were activated by culture on plastic, or culture on
sterile glass coverslips to allow subsequent immunoﬂuorescent staining.
RFP expression was induced in aHSCs from WT1CreERT2/+;Ai14 animals at day
6 of culture on glass coverslips by the addition of 1:1000 1 mM 4-hydroxytamoxifen
in ethanol to cultures. Cultures were examined by inverted ﬂuorescent microscopy
after 24 h to visualise native RFP expression, and then ﬁxed in ethanol:methanol 1:1
for 10min at −20 °C before immunoﬂuorescent staining.
For in vitro deletion of Wt1 from aHSCs during activation, isolated qHSCs
from WT1CreERT2/ﬂ;Ai14 animals and WT1CreERT2/+;Ai14 controls were cultured
to day 7 in the presence of 1:1000 1 mM 4-hydroxytamoxifen in ethanol.
In vitro morphometric analysis. qHSCs from uninjured WT1GFP/+ animals were
activated by 7 days of culture on plastic, and subpopulations deﬁned by Wt1(GFP)
expression obtained by FACS. Subpopulations were plated separately back onto
plastic and allowed to adhere overnight. Cells were labelled by addition of a non-
toxic ﬂuorescent surface dye (CellTracker Red CMTPX, Thermo Fisher Scientiﬁc),
as per manufacturer’s instruction, and examined by inverted ﬂuorescent micro-
scopy after 30 min using the EVOS FL Cell Imaging System (Thermo Fisher Sci-
entiﬁc). For subpopulation, ﬁve low-power images (×4 objective) were acquired.
‘Circularity’ of individual cells (4π(area perimeter−2)) was determined using
in FIJI.
Native RFP expression was used in place of the surface dye for morphometric
analysis of WT1CreERT2/ﬂ;Ai14 and WT1CreERT2/+;Ai14 aHSCs.
Transcriptomics. Cells were sorted by ﬂow cytometry directly into RLT (Qiagen)
containing β-ME to maintain sample integrity. RNA was isolated using RNeasy
Micro Kit (Qiagen).
For microarray data, whole-genome expression was determined with the
Illumina MouseWG-6 v2.0 Expression BeadChip after RNA preparation with the
Ambion Illumina TotalPrep RNA ampliﬁcation kit. Unnormalised summary probe
proﬁles were exported from BeadStudio to tab-delimited text ﬁles and read into the
R environment for analysis with Bioconductor60 package limma61. Expression data
were background corrected using negative controls, then quantile normalised and
ﬁnally log2 transformed. Differentially expressed probes were determined by ﬁtting
a linear model, and probes determined as up- or downregulated by decideTests
using the default arguments of adjustment of the p-value for multiple comparisons
(Benjamini and Hochberg method62) and an adjusted p-value threshold of 0.05.
RNAseq was undertaken by GATC Biotech on an Illumina HiSeq. Fastq ﬁles
were mapped with bowtie 263, and differential expression for subsequent GO and
SPIA analysis was determined by Cuffdiff264, using an adjusted p-value threshold
of 0.05. Differential expression for PCA was determined using DESeq265.
GO analysis for was undertaken with GOsummaries66 or Revigo (for knockout
experiments)67, using g:Proﬁler68 to ensure current Ensembl annotations are used.
Chord diagrams of differentially expressed genes related to speciﬁc GO annotations
were created using GOplot69. Pathway analysis was undertaken with SPIA70, after
updating KEGG pathway71 annotations (October 2016). SPIA combines
enrichment analysis with a measure of the actual pathway perturbation under a
given condition based on pathway topology, calculating a global pathway
signiﬁcance p-value combining the enrichment and perturbation p-values.
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Quantitative PCR. For the determination of gene expression by qPCR (undertaken
using an Applied Biosystems HT7900) on isolated cell populations, the Universal
ProbeLibrary (Roche) was used, and primers designed using the ProbeFinder web-
based tool based on Primer372. Sequences and probe numbers are shown in
Supplementary Table 10.
Quantiﬁcation and statistical analysis. The RStudio implementation of R was
used for all statistical analysis. Data are presented as mean ± s.e.m. All group sizes
(n) refer to biological replicates, either individual animals for in vivo studies or
independent cell isolations for in vitro studies. Validation qPCR was undertaken
using triplicate technical replicates for each biological replicate.
Prior to testing, the normality of data was determined using Shapiro–Wilk
testing and by examination of qq plots. For comparison of continuous variables
between two groups after assumptions of normality were satisﬁed, the Welch
(unequal variance) t-test was used73. For a comparison between more than two
groups, a one-way ANOVA with post-hoc Tukey was used. Distributions of
measured features of subpopulations from single animals were compared with a
bootstrap version of the Kolmogorov–Smirnov test56. To determine the correlation
between two variables, two-sided Spearman’s rank correlation coefﬁcients were
calculated.
Reporting summary. Further information on research design is available in the
Nature Research Reporting Summary.
Data availability
The RNAseq and microarray datasets generated and analysed in the study have been
deposited in the Gene Expression Omnibus (GEO), as accession number GSE103108.
The authors declare that all other relevant data supporting the ﬁndings of this study are
available within the Article and its Supplementary Information ﬁles, or from the
corresponding author on reasonable request. A reporting summary for this article is
available as a Supplementary Information ﬁle.
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